Indiana University Health Methodist Hospital is a hospital part of Indiana University Health, located in Indianapolis, state of Indiana, United States. It is the largest hospital in the state of Indiana and one of only three regional Level I Trauma Centers in the state.

There are 802 beds in IU Health Methodist Hospital.

During the past decade, IU Health Methodist Hospital conducted 117 clinical trials. In the 10-year time frame, 117 clinical trials started and 61 clinical trials were completed, i.e. on average, 52.1% percent of trials that started reached the finish line to date. In the past 5 years, 51 clinical trials started and 39 clinical trials were completed. i.e. 76.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "IU Health Methodist Hospital" #1 sponsor was "Indiana University" with 57 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 36 trials sponsored, "National Cancer Institute (NCI)" with 17 trials sponsored, "Indiana Kidney Stone Institute" with 12 trials sponsored and "Abbott Medical Devices" with 12 trials sponsored. Other sponsors include 100 different institutions and companies that sponsored additional 57 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "IU Health Methodist Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 24 trials as a collaborator, "NRG Oncology" with 12 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 8 trials as a collaborator, "Radiation Therapy Oncology Group" with 7 trials as a collaborator and "Indiana University School of Medicine" with 6 trials as a collaborator. Other collaborators include 104 different institutions and companies that were collaborators in the rest 75 trials.

According to Clinical.Site data, the most researched conditions in "IU Health Methodist Hospital" are "HIV Infections" (36 trials), "Adult Glioblastoma" (5 trials), "Adult Gliosarcoma" (5 trials), "Breast Cancer" (5 trials) and "Heart Failure" (5 trials). Many other conditions were trialed in "IU Health Methodist Hospital" in a lesser frequency.

Most popular intervention types in "IU Health Methodist Hospital" are "Drug" (93 trials), "Device" (57 trials), "Other" (55 trials), "Radiation" (28 trials) and "Procedure" (20 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (14 trials), "Quality-of-Life Assessment" (10 trials), "Placebo" (8 trials), "Zidovudine" (8 trials) and "Didanosine" (6 trials). Other intervention names were less common.

The vast majority of trials in "IU Health Methodist Hospital" are 206 trials for "All" genders, 18 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "IU Health Methodist Hospital". undefined are not yet recruiting, 33 are recruiting, 35 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 126 completed trials in IU Health Methodist Hospital, 2 suspended trials, and 26 terminated clinical trials to date.

Out of the total trials that were conducted in IU Health Methodist Hospital, 5 "Phase 1" clinical trials were conducted, 44 "Phase 2" clinical trials and 53 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 85 trials that are defined as “Not Applicable".